The use of SDSPAGE scanning of spent dialysate to assess uraemic toxin removal by dialysis

Nephrology Dialysis Transplantation

Volumn 26, Issue 7, 2011, Pages 2281-2289

  Ficheux, Alain ^a   Gayrard, Nathalie ^a   Szwarc, Ilan ^b   Andress, Daniel ^c   Soullier, Stphan ^a   Duny, Yohan ^a   Goubert, Gilles ^b   Thomas, Marie ^b   Bismuth Mondolfo, Johanna ^b   Daurs, Jean Pierre ^a   Brunet, Philippe ^d   Servel, Marie Françoise ^b   Argilés, Ángel ^a,b  

^a UNIV MONTPELLIER   (France)

^b Centre de Dialyse de Sete   (France)

^c Unitobio Laboratoire Andress Orbolato   (France)

^d AIX MARSEILLE UNIVERSITY   (France)

Author keywords

haemodialysis; middle molecules; protein removal into dialysate; SDSPAGE; spent dialysate

Indexed keywords

ALBUMIN; ALPHA 1 ANTITRYPSIN; BETA 2 MICROGLOBULIN; CREATININE; LEPTIN; RETINOL BINDING PROTEIN; UREA; UREMIC TOXIN; ALBUMINOID; DIALYSIS FLUID; PROTEIN; TOXIN;

AGED; ARTICLE; ARTIFICIAL KIDNEY; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIALYSATE; DIALYSATE LEVEL; DIALYSIS MEMBRANE; HORMONE BLOOD LEVEL; HUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RENAL REPLACEMENT THERAPY; UREA BLOOD LEVEL; BLOOD; CHRONIC KIDNEY FAILURE; METABOLISM; MOLECULAR WEIGHT; PROTEIN BINDING; UREMIA;

ALBUMINS; BETA 2-MICROGLOBULIN; DIALYSIS SOLUTIONS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; KIDNEY FAILURE, CHRONIC; MOLECULAR WEIGHT; PROTEIN BINDING; PROTEINS; RENAL DIALYSIS; RETINOL-BINDING PROTEINS; TOXINS, BIOLOGICAL; UREMIA;

EID: 79959928377     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq709     Document Type: Article

References (22)

1. Lowrie EG, Laird NM, Parker TF et al. Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med 1981; 305: 1176-1181. (Pubitemid 12237476)
2. Vanholder R, De Smet R, Glorieux G et alfor the European Uremic ToxinWork Group (EUTox). Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 2003; 63: 1934-1943. (Pubitemid 36513344)
3. European Uremic Toxins Work Group (EUTox). Uremic Solutes Database. http://www.nephro-leipzig.de/eutoxdb/index.php (17 November 2010, last accessed date).
4. Vanholder R, Eloot S, Van Biesen W. Do we need new indicators of dialysis adequacy based on middle-molecule removal? Nat Clin Pract Nephrol 2008; 4: 174-175. (Pubitemid 351451295)
5. Vanholder R, Baurmeister U, Brunet P et alfor the European Uremic Toxin Work Group. A bench to bedside view of uremic toxins. J Am Soc Nephrol 2008; 19: 863-870.
6. Clark WR, Ronco C. Determinants of haemodialyser performance and the potential effect on clinical outcome. Nephrol Dial Transplant 2001; 16: 56-60. (Pubitemid 32750431)
7. Locatelli F, Martin-Malo A, Hannedouche T et al. Effect of membrane permeability on survival of hemodialysis patients. J Am Soc Nephrol 2009; 20: 645-654.
8. Krieter DH, Lemke HD, Wanner C. A new synthetic dialyzer with advanced permselectivity for enhanced low-molecular weight protein removal. Artif Organs 2008; 32: 547-554. (Pubitemid 352000184)
9. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
10. Mares J, Thongboonkerd V, Tuma Z et al. Specific adsorption of some complement activation proteins to polysulfone dialysis membranes during hemodialysis. Kidney Int 2009; 76: 404-413.
11. Argilés A, Ficheux A, Thomas M et al. Precise quantification of dialysis using continuous sampling of spent dialysate and total dialysate volume measurement. Kidney Int 1997; 52: 530-537. (Pubitemid 27359600)
12. Argilés A, Mourad G, Basset N et al. Acute adaptative changes to unilateral nephrectomy in humans. Kidney Int 1987; 32: 714-720. (Pubitemid 17152402)
13. Bergstrom J, Wehle B. No change in corrected beta 2-microglobulin concentration after cuprophane haemodialysis. Lancet 1987; 329: 628-629. (Pubitemid 17024248)
14. Gotch FA, Sargent JA. A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 1985; 28: 526-534. (Pubitemid 15248043)
15. Aoike I. Clinical Significance of protein adsorbable membranes -long-term clinical effects and analysis using a proteomic technique. Nephrol Dial Transplant 2007; 22: S13-S19.
16. Chanard J, Caudwell V, Valeire J et al. Kinetics of 131I-β2 microglobulin in hemodialysis patients: assessment using total body counting. Artif Organs 1998; 22: 574-580. (Pubitemid 28324031)
17. Ishikawa I, Chikazawa Y, Sato K et al. Proteomic analysis of serum, outflow dialysate and adsorbed protein onto dialysis membranes (polysulfone and PMMA) during hemodialysis treatment using SELDI-TOF-MS. Am J Nephrol 2006; 26: 372-380. (Pubitemid 44394156)
18. Tian Q, Gomersall CD, Leung PPN et al. The adsorption of vancomycin by polyacrylonitrile, polyamide, and polysulfone hemofilters. Artif Organs 2008; 32: 81-84.
19. Fliser D, Novak J, Thongboonkerd Vet al. Advances in urinary proteome analysis and biomarker discovery. J Am Soc Nephrol 2007; 18: 1057-1071. (Pubitemid 46536892)
20. Weissinger EM, Nguyen-Khoa T, Fumeron C et al. Effects of oral vitamin C supplementation in hemodialysis patients: a proteomic assessment. Proteomics 2006; 6: 993-1000. (Pubitemid 43260223)
21. Weissinger EM, Kaiser T, Meert N et al. Proteomics: a novel tool to unravel the patho-physiology of uraemia. Nephrol Dial Transplant 2004; 19: 3068-3077. (Pubitemid 40057630)
22. Mann H, Melzer H, Al-Bashir A et al. Testing protein permeability of dialysis membranes using SDS-PAGE. Int J Artif Organs 2002; 25: 441-446